India's Life Sciences Industry Expands Globally

India's life sciences industry, known as the 'pharmacy of the world', has produced half of the eight billion vaccine doses distributed globally in the past year and is shifting towards innovation in personalized medicine and gene therapy. This sector is benefiting from technology adoption, including AI and digital health, and aims to capture a larger portion of the $36 billion global biosimilars market. Meanwhile, the Ontario Centre of Innovation is enhancing AI and life sciences innovation by connecting research and commercialization, offering funding and support to startups through various programs. A report by Amy Webb highlights the potential of combining AI, advanced sensors, and bioengineering to create 'living intelligence', which could disrupt multiple industries. Despite the advancements in AI, experts caution that its current applications in biology have limitations, emphasizing the need for further research and experimentation. The integration of diverse data types is seen as essential for the evolution of AI models and their application in real-world scenarios.